Precision diabetes treatment aims to answer a question clinicians and patients face every day: which diabetes drug is most likely to work best for this particular person? A new analysis from the TriMaster crossover trial offers an important clue. Researchers compared several precision-medicine strategies for predicting responses to sitagliptin, canagliflozin, …
Read More »
Could a stool sample someday help clinicians choose a diabetes medication before writing the prescription? Emerging research into gut biomarkers in diabetes is moving that possibility closer to clinical reality. Rather than simply cataloging which bacteria live in the intestine, researchers are examining microbial genes, stool-derived metabolites, and functional signatures …
Read More »
Managing type 2 diabetes today can feel like navigating a moving target. As new guidelines shift toward personalized, risk-based care, many clinicians ask the same question: how can a diabetes risk stratification approach be applied effectively in daily practice? This evolving approach is not just theoretical. Instead, it offers a …
Read More »
Managing diabetes in older adults isn’t just about adjusting medications—it’s about seeing the full picture of aging, frailty, and functionality. New 2025 standards highlight the need to assess frailty and functional status when setting A1C goals in elderly patients. But how do clinicians know when it’s time to de-intensify therapy …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.